Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 30,000 shares at $69.84 ($2.1M) on 2024-05-23, disclosed to the SEC on 2024-05-28.
Scheduled sale ($2.1M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.84 | 6,211 | $428K | 20.5% |
| 2 | $68.84 | 6,211 | $428K | 20.5% |
| 3 | $69.84 | 8,789 | $614K | 29.5% |
| 4 | $69.84 | 8,789 | $614K | 29.5% |
| Total | $69.43 avg | 30,000 | $2.1M | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |